Feeder-free culture of human embryonic stem cells in conditioned medium for efficient genetic modification.
about
Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeuticsPluripotent stem cell derived hepatocytes: using materials to define cellular differentiation and tissue engineeringRepair at single targeted DNA double-strand breaks in pluripotent and differentiated human cellsIsolation, differentiation and characterization of vascular cells derived from human embryonic stem cells.Human fetal liver stromal cells that overexpress bFGF support growth and maintenance of human embryonic stem cellsSirtuin 1 regulation of developmental genes during differentiation of stem cells.HIF-2α suppresses p53 to enhance the stemness and regenerative potential of human embryonic stem cells.Constitutive nuclear lamina-genome interactions are highly conserved and associated with A/T-rich sequenceChromosomal Modification in Human Embryonic Stem Cells Cultured in a Feeder-Free Condition after Single Cell Dissociation using Accutase.Feeder-dependent and feeder-independent iPS cell derivation from human and mouse adipose stem cells.CXCR2 and its related ligands play a novel role in supporting the pluripotency and proliferation of human pluripotent stem cellsDevelopment of stem cell-based therapy for Parkinson's disease.Development of a novel two-dimensional directed differentiation system for generation of cardiomyocytes from human pluripotent stem cellsLong term non-invasive imaging of embryonic stem cells using reporter genesRapid generation of mature hepatocyte-like cells from human induced pluripotent stem cells by an efficient three-step protocol.Fast and efficient multitransgenic modification of human pluripotent stem cells.Allele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes.Cardiomyocyte differentiation of pluripotent stem cells and their use as cardiac disease models.In vitro uses of human pluripotent stem cell-derived cardiomyocytes.The case for induced pluripotent stem cell-derived cardiomyocytes in pharmacological screening.Current status of drug screening and disease modelling in human pluripotent stem cells.PRMT8 Controls the Pluripotency and Mesodermal Fate of Human Embryonic Stem Cells By Enhancing the PI3K/AKT/SOX2 Axis.Precise and efficient scarless genome editing in stem cells using CORRECT.Adaptation to robust monolayer expansion produces human pluripotent stem cells with improved viability.Cultivation with untransfected fibroblasts stimulates proliferation of a single gene-modified fibroblast derived from a clawn miniature swine foetus.Transfecting and nucleofecting human induced pluripotent stem cellsCDK1-PDK1-PI3K/Akt signaling pathway regulates embryonic and induced pluripotencyDerivation, propagation and controlled differentiation of human embryonic stem cells in suspension.Genetic manipulation of human induced pluripotent stem cells.Seamless genome editing in human pluripotent stem cells using custom endonuclease-based gene targeting and the piggyBac transposon.Transcriptional expression profile of cultured human embryonic stem cells in vitro and in vivo.Laminin regulates mouse embryonic stem cell migration: involvement of Epac1/Rap1 and Rac1/cdc42.Clonal analysis of individual human embryonic stem cell differentiation patterns in microfluidic cultures.A fully defined static suspension culture system for large-scale human embryonic stem cell production
P2860
Q26825384-CD5E0247-DE7E-49C0-95E8-2DECC88F1B72Q28076413-0DBC43FF-3DCC-4D3A-BA93-5EF636AFE087Q28478289-EF33AE9D-9D0F-4B13-9988-982CD785FFFCQ33760945-92C63D86-7C8B-4496-B8E2-6198D0707AE0Q33786850-0351B22C-1E11-4D10-BB3C-0D315A39473EQ34068359-9BBEA68C-3640-4624-8D91-E90E48BDFD11Q34280670-58B91FCB-AE6D-435B-8CB1-9FE1AA6FF6D9Q34309873-328C7F08-4D93-42B3-87E8-4C3320CEF13FQ34804422-CBDEE908-F073-421A-B818-09FB002DFC6CQ34952899-7427230E-0E63-4AB1-9F02-67148447E774Q35324646-F9571866-B678-4B7E-A098-423C96B9B216Q36025246-C2B51867-2B21-4D4F-A9B1-161AE8B21A73Q36565384-44AC0243-3A77-40D9-9013-8FD140A4C33AQ36931684-8200B778-B1F6-476D-A686-7CA172600E87Q37188211-6F87EDDE-0621-4BDF-A8B7-E262AC5F8DA1Q37710740-B98FD0A8-C15A-48E5-92CD-98A74A50A247Q37711518-22883FD0-E3C6-41C4-85DE-DF665116A4DDQ37832530-CC87CE8E-0386-405C-82BA-804A564E2BBBQ38013733-23295C59-4FD6-4E73-A2E9-85D2D4B0A8AAQ38030589-1C8A6BC0-EC4B-4567-A687-94FB1E1A26B5Q38034129-E0E715DD-3865-4494-BBA8-C6CB21552A0AQ38402556-74DF77D7-DEDE-43CF-81DD-2B53F7D2D10AQ38720592-45D07EED-F5AB-485A-AE35-85996E31F414Q39181538-CA15E038-B498-4EDD-9A7D-A0DABE9A2810Q39476597-3BFDC1E6-58E3-4842-96B8-E0E47ABF4674Q39478620-3F90C0EB-55C6-4EE1-885A-293856C2258CQ42328309-82F4ED28-2F6F-4AFB-BA48-F201DBB049DAQ42813703-3CD0D8C6-A0C6-4C6B-8A4C-B98764E51A05Q46242018-3DFB95B3-D135-4D6E-8043-DDEBAD5DAB00Q48925635-7BEBE5C7-C0A2-4B0D-A31D-3EB3AE6ECB87Q51817479-C0A0CA0A-DA03-4A5F-A191-1047F601CA63Q52598198-18002217-B74C-4CC5-874B-A603F64BA6F9Q53473447-6BA2A5CD-E20D-45C9-A0FE-308106620111Q57166636-AA8E8F99-6930-4C04-9C1C-FAFC98FCCF76
P2860
Feeder-free culture of human embryonic stem cells in conditioned medium for efficient genetic modification.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Feeder-free culture of human e ...... fficient genetic modification.
@en
Feeder-free culture of human e ...... fficient genetic modification.
@nl
type
label
Feeder-free culture of human e ...... fficient genetic modification.
@en
Feeder-free culture of human e ...... fficient genetic modification.
@nl
prefLabel
Feeder-free culture of human e ...... fficient genetic modification.
@en
Feeder-free culture of human e ...... fficient genetic modification.
@nl
P2093
P2860
P356
P1433
P1476
Feeder-free culture of human e ...... fficient genetic modification.
@en
P2093
Elena Matsa
Lorraine E Young
Robert Passier
Stefan R Braam
P2860
P2888
P304
P356
10.1038/NPROT.2008.140
P577
2008-01-01T00:00:00Z